2006 - 2007 Research of sphingosine kinase modification in acute lung injury
2007 - スフィンゴシンキナーゼの細胞質・核間シャトル機構の解析
2006 - 糖尿病をモデルとしたシグナル伝達病拠点
2006 - 急性肺傷害に対するスフィンゴリン脂質代謝酵素を用いた遺伝子治療の試み
2005 - 糖尿病をモデルとしたシグナル伝達病拠点
2005 - スフィンゴシン1リン酸に結合する核内受容体の同定
2002 - 2003 エンドソーム形成の分子メカニズムの解析
2000 - 2001 低分子G蛋白質ARF依存性ホスホリパーゼDの活性化機構の解析
1999 - 2000 Studies on the mechanism of activation of phospholipase D
1998 - 1998 G_<M2>アクチベーターによるホスホリパーゼDの活性化機構に関する研究
Show all
Papers (47):
Susumu Nishida, Shubi Ambwene Matovelo, Taketoshi Kajimoto, Shun-Ichi Nakamura, Taro Okada. Involvement of sphingosine 1-phosphate signaling in insulin-like growth factor-II/mannose 6-phosphate receptor trafficking from endosome to the trans-Golgi network. Communications biology. 2024. 7. 1. 1182-1182
Susumu Nishida, Shubi Ambwene Matovelo, Taketoshi Kajimoto, Shun-Ichi Nakamura, Taro Okada. Extracellular α-synuclein impairs sphingosine 1-phosphate receptor type 3 (S1PR3)-regulated lysosomal delivery of cathepsin D in HeLa cells. Genes to cells : devoted to molecular & cellular mechanisms. 2024. 29. 3. 207-216
Nana Sakakibara, Takeshi Ijuin, Tomoko Horinouchi, Tomohiko Yamamura, China Nagano, Eri Okada, Shinya Ishiko, Yuya Aoto, Rini Rossanti, Takeshi Ninchoji, et al. Identification of novel OCRL isoforms associated with phenotypic differences between Dent disease-2 and Lowe syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2022. 37. 2. 262-270
Taro Okada, Susumu Nishida, Lifang Zhang, Nesma Nabil Ibrahim Mohamed, Tianyou Wang, Takeshi Ijuin, Taketoshi Kajimoto, Shun-Ichi Nakamura. Constitutive activation of S1P receptors at the trans-Golgi network is required for surface transport carrier formation. iScience. 2021. 24. 11. 103351-103351
Taro Okada, Shun-ichi Nakamura. [Role of S1P acting both inside and outside the cells]. Seikagaku. The Journal of Japanese Biochemical Society. 2012. 84. 2. 92-101